The mainstay of treatment for retinal vein occlusion is for early detection of the condition, to identify and treat any underlying risk factors and treat sight-threatening complications such as fluid build up in the central retina (macular oedema).
New treatments for macular oedema have transformed the outlook for patients with retinal vein occlusion. These involve the injection of a highly specialised and targeted medicine into the gel-like fluid of the eye (the vitreous). The medicine works by blocking the protein responsible for the leakage of retinal blood vessels in retinal vein occlusion.
Injection treatments for macular oedema aim to stop the bleeding and leakage of fluid from retinal blood vessels. Ongoing regular injections are needed to help stabilise the condition.